The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...
Medical Device Network on MSN8d
Newronika’s DBS device gains CE Mark approval for Parkinson’s treatmentNewronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.
Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has ...
Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.
MILAN, March 24, 2025 /PRNewswire/ -- Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its ...
Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe. This closed-loop deep brain stimulation (DBS) device claims to adjust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback